ProfessorCamille Raynes-Greenow

Professor Camille Raynes‑Greenow leads several major research programmes examining how environmental and behavioural factors influence maternal and child health, particularly in low‑ and middle‑income countries. Her work includes Poriborton, a large, cluster RCT investigating the impacts of household air pollution from biomass fuels on pregnancy and early child health, developed through deep collaboration with partners in Bangladesh and India and supported by NHMRC. She is also collaborating on the HeAT, Cohort study.  A multidisciplinary cohort study exploring the effects of extreme heat on pregnancy, maternal wellbeing and neonatal outcomes, integrating environmental monitoring, epidemiological analysis and community‑based adaptation strategies to inform climate‑resilient health systems.

In addition, our new student project is an IPD Meta‑analysis Project, which brings together global datasets to generate harmonised evidence on the impacts of household air pollution exposure during pregnancy on birth outcomes and newborn health.

Her research also extends to modifiable risk factors (behavioural and clinical) including studies on maternal sleep position and its association with adverse pregnancy outcomes, with the aim of developing clear, culturally sensitive public health guidance. She contributes further to global maternal health through projects examining iron and folic acid (IFA) supplementation, focusing on adherence, health system barriers and the effects of IFA use on maternal anaemia, pregnancy outcomes and early child health.

Professor Raynes‑Greenow has an extensive supervisory record across Honours, Master’s and PhD levels. Her students work across perinatal epidemiology, environmental health, global health and implementation science, often embedded within international collaborations. Her supervisory approach is supportive, structured and focused on building methodological capability, fostering independent thinking and developing researchers whose work contributes directly to improved health outcomes for women and children globally.